Hostname: page-component-74656f9884-npj9w Total loading time: 0 Render date: 2026-11-07T09:52:43.434Z Has data issue: false hasContentIssue false

Management of inverted papilloma: review

Published online by Cambridge University Press:  09 February 2017

B Attlmayr*
Affiliation:
ENT Department, Aintree University Hospital, Liverpool, UK
S G Derbyshire
Affiliation:
ENT Department, Aintree University Hospital, Liverpool, UK
A V Kasbekar
Affiliation:
ENT Department, Aintree University Hospital, Liverpool, UK
A C Swift
Affiliation:
ENT Department, Aintree University Hospital, Liverpool, UK
*
Address for correspondence: Dr B Attlmayr, ENT Department, Aintree University Hospital, Longmoor Lane, Liverpool L9 7AL, UK Fax: 00 44 151 529 5237 E-mail: bernhard.attlmayr@aintree.nhs.uk
Rights & Permissions [Opens in a new window]

Abstract

Background:

Inverted papilloma is the most common benign tumour affecting the nose. There is a high rate of recurrence and a potential of malignant transformation. This review article aimed to identify the best available management of this pathology today.

Method:

A systematic review of the current English-language literature was performed. Only original articles with a minimum follow up of one year and an average follow up of two years were included.

Results:

A total of 1385 patients from 16 case series were identified. The total recurrence rate for all patients was 11.5 per cent. Significantly lower recurrence rates were found for procedures using an attachment-oriented excision (recurrence of 6.9 per cent; p = 0.0001) and utilising frozen sections (recurrence of 7.0 per cent; p = 0.0001).

Conclusion:

There is a general trend towards endoscopic surgery. There may be some benefit to the use of attachment-oriented surgery and frozen sections. Multi-centred randomised controlled trials are required.

Information

Type
Review Articles
Copyright
Copyright © JLO (1984) Limited 2017 
Figure 0

Table I Krouse staging system for inverted papilloma18

Figure 1

Fig. 1 Flow chart of search strategy.

Figure 2

Table II Approach and recurrence data for the included case series